Physician profile
Mark Karides
NPI 1932206307
$16,604.21
in general payments reported to CMS, 2019-2025
75 companies · $2,551 in 2025
The $2,551 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,276 · 2020: $844 · 2021: $1,872 · 2022: $2,305 · 2023: $2,948 · 2024: $2,807 · 2025: $2,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,282 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,281.57 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,046.38 | 2019-2025 | Kisqali, Piqray |
| Janssen Biotech, INC. | $1,576.31 | 2019-2025 | Tecvayli, Talvey, Erleada |
| Celgene Corporation | $1,084.25 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $1,049.47 | 2019-2025 | Reblozyl, Opdualag, Opdivo |
| Astrazeneca Pharmaceuticals Lp | $1,033.56 | 2019-2025 | Lynparza, Imfinzi, Tagrisso |
| Abbvie INC. | $956.91 | 2019-2025 | |
| Pfizer INC. | $808.02 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $673.29 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Beigene USA, INC. | $660.34 | 2020-2024 | Brukinsa, Tevimbra |
| Genentech USA, INC. | $391.74 | 2019-2025 | Polivy, Perjeta, Phesgo |
| Glaxosmithkline, LLC. | $379.46 | 2022-2025 | Zejula, Jemperli, Ojjaara |
| Amgen INC. | $374.77 | 2019-2023 | Lumakras, Vectibix, Nplate |
| Gilead Sciences, INC. | $372.58 | 2022-2025 | Trodelvy |
| Astellas Pharma US INC | $336.43 | 2019-2025 | Xospata, Xtandi, Padcev |
| Tg Therapeutics, INC. | $324.39 | 2021-2022 |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $311.73 | 2020-2024 | Monjuvi, Pemazyre |
| Seagen INC. | $239.97 | 2019-2023 | Tukysa |
| Takeda Pharmaceuticals U.S.A., INC. | $212.99 | 2019-2025 | Alunbrig, Iclusig |
| Pharmacyclics LLC, An Abbvie Company | $212.60 | 2019-2023 | Imbruvica |
| Genzyme Corporation | $199.15 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $181.08 | 2019-2025 | Zepzelca |
| Boston Scientific Corporation | $172.88 | 2022-2024 | |
| Octapharma USA, INC. | $164.17 | 2022-2023 | Octagam Immune Globulin (Human) |
| Emd Serono, INC. | $151.11 | 2019-2023 | Bavencio |
| Karyopharm Therapeutics INC. | $142.48 | 2020-2021 | |
| Lilly USA, LLC | $137.95 | 2019-2022 | |
| Daiichi Sankyo INC. | $120.55 | 2024-2025 | Enhertu, Datroway |
| Kite Pharma, INC. | $114.72 | 2021-2025 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $112.45 | 2019-2023 | |
| Agios Pharmaceuticals, INC. | $108.67 | 2020-2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $105.09 | 2021-2023 | Qinlock |
| Servier Pharmaceuticals LLC | $101.31 | 2022-2024 | |
| G1 Therapeutics, INC. | $99.97 | 2022-2023 | Cosela |
| Exelixis INC. | $89.65 | 2019-2022 | |
| Tersera Therapeutics LLC | $89.61 | 2022-2024 | Xermelo |
| Pharmacosmos Therapeutics INC. | $86.69 | 2023-2024 | Cosela, Monoferric |
| Blueprint Medicines Corporation | $80.26 | 2023-2025 | Ayvakit |
| Amneal Pharmaceuticals LLC | $74.30 | 2024-2025 | Avastin, Alymsys |
| Eisai INC. | $74.01 | 2023-2024 | |
| Adaptive Biotechnologies Corporation | $62.18 | 2023-2025 | Clonoseq |
| Mirati Therapeutics, INC. | $54.51 | 2023-2024 | Krazati |
| Kyowa Kirin, INC. | $54.06 | 2020-2024 | Poteligeo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.43 | 2020 | |
| Rigel Pharmaceuticals, INC. | $47.05 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Cti Biopharma Corp. | $46.58 | 2022-2023 | Vonjo |
| Recordati_rare_diseases_inc. | $46.37 | 2025 | Enjaymo |
| Taiho Oncology, INC. | $46.11 | 2023-2024 | |
| Aveo Pharmaceuticals, INC. | $45.90 | 2022 | |
| Tempus Ai, INC | $44.60 | 2024-2025 | Xt Cdx |
| Adc Therapeutics America, INC. | $42.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $42.75 | 2020 | |
| Puma Biotechnology, INC. | $37.76 | 2020-2023 | |
| Springworks Therapeutics, INC. | $37.00 | 2025 | Ogsiveo |
| Epizyme, INC. | $34.82 | 2023-2024 | Tazverik, Onivyde |
| Ge Healthcare | $34.36 | 2024 | |
| Biocon Biologics INC | $31.62 | 2023-2024 | Hulio, Fulphila |
| Syndax Pharmaceuticals, INC. | $29.25 | 2025 | |
| Secura Bio, INC. | $28.55 | 2021 | |
| Sumitomo Pharma America, INC. | $27.69 | 2025 | Orgovyx |
| Geron Corporation | $26.19 | 2025 | Rytelo |
| Intuitive Surgical, INC. | $26.16 | 2022 | |
| Amag Pharmaceuticals, INC. | $24.63 | 2021 | |
| Immunocore Limited | $24.04 | 2024 | Kimmtrak |
| Accord Healthcare, INC. | $23.34 | 2025 | |
| Organon LLC | $19.79 | 2022 | |
| Morphosys, US INC. | $19.61 | 2022 | |
| Iovance Biotherapeutics, INC. | $19.50 | 2024-2025 | Amtagvi |
| Verity Pharmaceuticals INC. | $19.07 | 2023 | Trelstar |
| Sobi, INC | $18.89 | 2025 | |
| Dova Pharmaceuticals | $18.02 | 2020 | |
| Melinta Therapeutics, LLC | $17.08 | 2023 | Rezzayo, Vabomere |
| Array Biopharma INC | $15.99 | 2022 | |
| Advanced Accelerator Applications | $13.57 | 2019 | |
| Verastem, INC. | $13.33 | 2019 | |
| Fortovia Therapeutics, INC. | $6.21 | 2020 |
Drugs and devices associated with these payments
Reblozyl $888Venclexta $618Kisqali $492Keytruda $295Fabhalta $261Zejula $255Jemperli $255Scemblix $242Lynparza $210Opdualag $208Pomalyst $203Imbruvica $201Opdivo $175Brukinsa $174Elrexfio $159Adcetris $149Epkinly $147Xtandi $140Padcev $135Cosela $132Alunbrig $123Piqray $117Monjuvi $109Ibrance $109Tukysa $108Trodelvy $101Octagam Immune Globulin (Human) $99.47Zepzelca $98.98Bosulif $95.00Yescarta $94.56Enhertu $92.40Pluvicto $85.36Tibsovo $83.97Ayvakit $80.26Promacta $75.08Lenvima $74.01Bavencio $72.24Inlyta $71.62Orgovyx $71.37Xermelo $64.80Pyrukynd $64.21Xospata $62.60Clonoseq $62.18Krazati $54.51Tasigna $53.20Keytruda Qlex $53.18Lutathera $52.97Emrelis $52.47Mekinist $52.40Lorbrena $49.00Ojjaara $48.70Avastin $47.53Tavalisse $47.05Rezlidhia $47.05Sarclisa $46.39Enjaymo $46.37Inqovi $46.11Lonsurf $46.11Talzenna $45.97Zynlonta $42.91Stivarga $41.48Vitrakvi $41.48Vonjo $41.47Ogsiveo $37.00Poteligeo $35.13Lumakras $32.65Talvey $30.31Vyloy $30.31Tecvayli $30.31Iclusig $28.83Datroway $28.15Pemazyre $27.24Alymsys $26.77Rytelo $26.19Blenrep $25.00Qinlock $24.99Xalkori $24.82Imfinzi $24.46Braftovi $24.18Mektovi $24.18Polivy $24.07Kimmtrak $24.04Tagrisso $23.75Camcevi $23.34Nplate $23.04Vectibix $23.04Gavreto $22.73Besponsa $22.17Cerdelga $20.99Kadcyla $20.93Perjeta $20.93Phesgo $20.93Tevimbra $20.86Erleada $20.19Tazverik $19.60Amtagvi $19.50Trelstar $19.07Vabomere $17.08Rezzayo $17.08Hulio $16.03
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Karides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.